In cancer trials, clinical investigators report and grade adverse events on behalf of their patients via the Common Terminology Criteria for Adverse Events (CTCAE) scale—including for highly subjective events such as fatigue, nausea, or sensory neuropathy. However, this approach has been found to be unreliable.
[Comment] Sharing patient-reported outcomes with clinical investigators in real time
The Lancet Oncology | | Ethan Basch, Amylou Dueck
Topics: oncology